Dr Arvind Arora
Consultant Medical Oncologist & Honorary (Clinical) Associate Professor
MBBS, PgC (Oncology), MSc (Oncology), MRCP (Medical oncology), DM (Oncology), FRCP (UK)
Practices at: BMI The Park Hospital
He has been a Consultant in Medical Oncology at Nottingham University Hospitals NHS Trust (NUH) since 2015.
He commenced his oncology career after completing his general medical training at University Hospitals of Leicester NHS Trust in 2007. He went on to complete his medical oncology training through the East Midlands Medical Training Programme.
Dr Arora was awarded a Postgraduate Certificate in Oncology from Newcastle University with distinction. He has an MSc in Oncology from the University of Nottingham with a research project on Pancreatic and Bile Duct cancer. He was awarded a doctorate degree (DM in Oncology) from the University of Nottingham for his lab-based research work evaluating the role of RecQ helicases in Breast Cancer. He completed acute oncology training from Liverpool University.
Dr Arora is actively involved in audits, research, clinical trials, and teaching. He is a clinical trial lead and audit lead for the Oncology Department at NUH. He is the principal investigator for several national, international, commercial, and non-commercial oncology clinical trials at NUH. He has several publications in well-reputed peer-reviewed journals and is the module convenor for the MSc Oncology course at the University of Nottingham.
In 2017 The University of Nottingham recognised his research and teaching work and awarded him the title of Honorary Clinical Associate Professor.
Dr Arvind Arora was awarded the iWantGreatCare Certificate of Excellence in 2020 for delivering outstanding care, reflected in the 5-star rating awarded to him on this review site by his patients.
- FRCP (Fellow of Royal College of Physicians, UK)
- ENETS (European Neuroendocrine Tumor Society)
- BTOG (British Thoracic Oncology Group)
- Pancreatic Cancer UK
- AMMF (Cholangiocarcinoma charity)
Treatments provided: Chemotherapy; Immunotherapy; Targeted Therapies, Endocrine Therapies.
Tumour Sites treated:
- HPB (Liver, Bile Duct, Gall Bladder, Ampullary and Pancreatic cancer)
- NETs (Neuroendocrine tumours- all sites)
- Lung cancer
- Breast cancer
Ways to pay
Pay for yourself
Pay for yourself with our fixed price packages. This includes your pre-assessment, treatment, follow-ups and 6 months' aftercare
Pay with health insurance
We are widely recognised by health insurers. Ask your insurer about your cover and for an insurer pre-authorisation code
Spread the cost
Pay for yourself with monthly repayments spread over 12 months, interest-free (terms and conditions apply)